Human Investing’s Vertex Pharmaceuticals VRTX Stock Holding History

Human Investing’s Portfolio VRTX Stock Details VRTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q1	–	Sell	-10	Closed	-$4.03K	–	301
2024 Q4	$4.03K	Buy	+10	New	+$4.63K	﹤0.01%	238
2021 Q2	–	Sell	-20	Closed	-$4K	–	286
2021 Q1	$4K	Hold	20	–	–	﹤0.01%	266
2020 Q4	$5K	Hold	20	–	–	﹤0.01%	259
2020 Q3	$5K	Sell	20 -106	-84%	-$29.2K	﹤0.01%	254
2020 Q2	$37K	Buy	126 +106	+530%	+$28.7K	0.01%	163
2020 Q1	$5K	Sell	20 -118	-86%	-$27.1K	﹤0.01%	247
2019 Q4	$30K	Buy	138 +118	+590%	+$23.9K	0.01%	227
2019 Q3	$3K	Hold	20	–	–	﹤0.01%	326
2019 Q2	$4K	Hold	20	–	–	﹤0.01%	309
2019 Q1	$4K	Hold	20	–	–	﹤0.01%	296
2018 Q4	$3K	Buy	+20	New	+$3.46K	﹤0.01%	333

Other funds holding VRTX

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return

Human Investing's VRTX Position: Q1 2025 in Review

Human Investing sold out of Vertex Pharmaceuticals (VRTX) in Q1 2025, closing a stake of 10 shares — an estimated $4.03K sold.

Human Investing first reported a position in VRTX in Q4 2018 and held it in 11 quarters. The position peaked at $37K in Q2 2020. 1,612 funds tracked by Wall St. Rank hold VRTX as of Q1 2025.

Human Investing reported no remaining Vertex Pharmaceuticals position as of Q1 2025 after selling out during the quarter.
Human Investing sold 10 Vertex Pharmaceuticals shares in Q1 2025, an estimated $4.03K.
Human Investing first reported a position in Vertex Pharmaceuticals in Q4 2018 and held it in 11 quarters.
Human Investing's Vertex Pharmaceuticals position peaked at $37K in Q2 2020.
1,612 funds tracked by Wall St. Rank held Vertex Pharmaceuticals as of Q1 2025.

Based on Human Investing's 13F filing for Q1 2025, filed 15 May 2025.